Global COPD Drugs Market Key Manufacturers Analysis, Demands, Cost and Forecasts to 2023
Global COPD Drugs Market Research Report provides analysis of Drug type, Pipeline drugs, competitive landscapes, key manufacturers profiles, Industry size, share, demands and forecasts to 2023.
Pune, India – March 25, 2019 /MarketersMedia/ —
“Global COPD Drugs Market: Analysis By Drug Type (Combination Therapy Drugs, Anticholinergics, Beta-Agonist, Inhaled Corticosteroids, Others), Pipeline Drugs, By Region, By Country (2019 Edition): Forecast to 2023 – By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, Germany, U.K, France, Italy, China, Japan, India)”, the COPD Drugs Market is projected to display robust growth represented by a CAGR of 2.47% during 2018 – 2023.
Company Profiles:
1 GSK
2 AstraZeneca
3 Boehringer-Ingelheim
4 Teva Pharmaceuticals
5 Chiesi Farmaceutici S.p.A.
6 Novartis
7 Cipla
8 Mylan
9 Vectura Group Plc,
10 Sunovion
Over the recent years, COPD Drugs market has been witnessing growth on account of several driving factors including growing prevalence of COPD associated diseases, rising patient population, and increase in availability of novel combination therapy drugs. Moreover, increasing awareness regarding COPD, high smoking prevalence, rising pollution level, growing medical spending, favorable government initiatives, public private partnership have been driving the market growth. In addition, rising geriatric population, increasing global healthcare expenditure and technological advancements in pharmaceuticals research, and growing scope in middle and low income countries with large patient population is anticipated to impel the market growth of the COPD drugs market. However, growing portfolio of generic COPD drugs, and patent expiration of few innovator drugs in upcoming years are expected to hinder the market performance during forecasted period.
Get Discount on Global COPD Drugs Market Research Report at https://www.reportsnreports.com/contacts/discount.aspx?name=1984688
In this research report, the market is segmented on the basis of drug type. By drug type, the combination therapy COPD drugs are predicted to hold their dominant position in the market, especially LABA/LAMA and triple combination ICS/LABA/LAMA market is expected to gain more traction in forecasted period. Amongst the regions, North America accounts for the largest regional share in the global COPD drugs market in 2017. The largest share of North America is attributed to presence of enormous number of patient base and more emphasis towards prescribed branded drugs.
The report titled “Global COPD Drugs Market: Analysis By Drug Type (Combination Therapy Drugs, Anticholinergics, Beta-Agonist, Inhaled Corticosteroids, Others), Pipeline Drugs, By Region, By Country (2019 Edition): Forecast to 2023 – By Region (North America, Europe, APAC, ROW), By Country (U.S., Canada, Germany, U.K, France, Italy, China, Japan, India” has covered and analysed the potential of COPD drugs market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the COPD drugs market. Additionally, the report also highlights market entry strategies for various companies across the globe along with pipeline and product analysis.
Direct Purchase of Global COPD Drugs Market Research Report at https://www.reportsnreports.com/purchase.aspx?name=1984688
Scope of the Report
Global COPD Drugs Market (Actual Period: 2013-2017, Forecast Period: 2018-2023)
• COPD Drugs Market– Size, Growth, Forecast
• Analysis By Drug Type – Combination Therapy COPD Drugs, Anticholinergics COPD Drugs, Beta-Agonist COPD Drugs, Inhaled Corticosteroids COPD Drugs, and Other COPD Drugs.
Regional COPD Drugs Market – North America, Europe, Asia Pacific, Rest of the World (Actual Period: 2013-2017, Forecast Period: 2018-2023)
• COPD Drugs Market– Size, Growth, Forecast
• Analysis By Drug Type – Combination Therapy COPD Drugs, Anticholinergics COPD Drugs, Beta-Agonist COPD Drugs, Inhaled Corticosteroids COPD Drugs, and Other COPD Drugs.
Country Analysis – U.S., Canada, Germany, U.K, France, Italy, China, Japan, India (Actual Period: 2013-2017, Forecast Period: 2018-2023)
• COPD Drugs Market – Size, Growth, Forecast
• Analysis By Drug Type – Combination Therapy COPD Drugs, Anticholinergics COPD Drugs, Beta-Agonist COPD Drugs, Inhaled Corticosteroids COPD Drugs, and Other COPD Drugs.
Other Report Highlights
• Pipeline Analysis- PT010, Duaklir, Nemiralisib, Danirixin.
• Product Analysis.
• Market Dynamics – Drivers and Restraints.
• Market Trends.
• Porter Five Forces Analysis.
• SWOT Analysis.
• Company Analysis – Glaxo SmithKline, AstraZeneca, Boehringer-Ingelheim, TEVA Pharmaceuticals, Chiesi Pharmaceuticals, Novartis, Merck, Cipla, Mylan, Vectura, and Sunovion.
For More Details on Global COPD Drugs Market Research Report at https://www.reportsnreports.com/contacts/inquirybeforebuy.aspx?name=1984688
Table of Contents:
1. Research Methodology
2. Executive Summary
3. Strategic Recommendations
4. COPD Drugs Products Outlook
5. Global COPD Drugs Market: Growth and Forecast
6. Global COPD Drugs Market: Segment Analysis
7. Global COPD Drugs Market: Regional Analysis
8. North America COPD Drugs Market: Growth and Forecast
9. Europe COPD Drugs Market: Growth and Forecast
10. APAC COPD Drugs Market: Growth and Forecast
11. ROW COPD Drugs Market: Growth and Forecast
12. Global COPD Drugs Market: Pipeline Analysis
13. Global COPD Drugs Market: Market Dynamics
14. Porter Five Force Analysis
15. SWOT Analysis
16. Company Profiles
Contact Info:
Name: Ganesh Pardeshi
Email: Send Email
Organization: ReportsnReports
Website: https://www.reportsnreports.com/reports/1984688-global-copd-drugs-market-analysis-by-drug-type-combination-therapy-anticholinergics-beta-agonist-inhaled-corticosteroids-others-pipeline-drugs-by-region-by-country-2019-edition-forecast-to-2023-by-r-an-india.html
Source: MarketersMedia
Release ID: 495117
Copyright © 1999-2013 SproutNews.com
